December 25, 2024 - 20:25

In the world of investing, distinguishing between a market correction and a dip is essential for making informed decisions. Recently, Callie Cox, Chief Market Strategist at Ritholtz Wealth Management, shared her insights on this topic during an episode of Stocks In Translation.
Cox defines a market correction as a decline of 10% from the highest price reached in the past year. She emphasizes the importance of accepting market fluctuations, noting that investors will inevitably experience both ups and downs. According to her, a significant drop, particularly one of 20%, often indicates a more profound shift in the economy and financial markets, especially in relation to employment trends.
On the other hand, she suggests that smaller drops, ranging from 5% to 10%, should be viewed as minor adjustments, or "icing on the cake," for seasoned investors. Understanding these distinctions can help investors navigate the complexities of the market and make strategic decisions for their portfolios.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...